Clinical Trial Update: SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the renoprotective effects of SGLT2 inhibitors and their impact on bone health in lupus nephritis patients; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Osteoporosis

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Mansoura University | Conditions: SGLT2 INHIBITORS, Lupus Nephritis | Phase 4 | Status: COMPLETED